Skip to main content
BrainCited
Figure 13

Beschreibung

Subgroup analyses stratify cognitive outcomes by baseline DHA status, revealing whether individuals with lower initial omega-3 levels benefit more from supplementation.

More Figures from This Paper

Blood levels of DHA, EPA, and arachidonic acid are tracked over the intervention period, confirming adherence and bioavailability of the fatty acid supplement.

Figure 6

Blood levels of DHA, EPA, and arachidonic acid are tracked over the intervention period, confirming adherence and bioavailability of the fatty acid supplement.

chart
Plasma lutein and zeaxanthin concentrations are compared between treatment and control groups, demonstrating successful supplementation and absorption.

Figure 7

Plasma lutein and zeaxanthin concentrations are compared between treatment and control groups, demonstrating successful supplementation and absorption.

chart
Macular pigment optical density measurements assess the accumulation of lutein and zeaxanthin in the retina following supplementation.

Figure 8

Macular pigment optical density measurements assess the accumulation of lutein and zeaxanthin in the retina following supplementation.

chart
Verbal memory test performance including word recall and recognition tasks is compared between supplementation and placebo groups.

Figure 9

Verbal memory test performance including word recall and recognition tasks is compared between supplementation and placebo groups.

chart
Visual memory and spatial recall scores are assessed following LCPUFA and lutein/zeaxanthin supplementation compared to placebo.

Figure 10

Visual memory and spatial recall scores are assessed following LCPUFA and lutein/zeaxanthin supplementation compared to placebo.

chart
Working memory and executive function task results are presented for both treatment arms, assessing broader cognitive effects of the combined supplementation.

Figure 11

Working memory and executive function task results are presented for both treatment arms, assessing broader cognitive effects of the combined supplementation.

chart

Figure 13

Chart
1032 × 183px · 44,1 KB

Source Paper

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin on Episodic Memory in Healthy Older Adults.

Nutrients (2023)

PMID: 37447152

DOI: 10.3390/nu15132825

Cite This Figure

![Figure 13: Subgroup analyses stratify cognitive outcomes by baseline DHA status, revealing whether individuals with lower initial omega-3 levels benefit more from supplementation.](https://pdfs.citedhealth.com/figures/37447152/218.png)

> Source: Toshiaki Sueyasu et al. "Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and." *Nutrients*, 2023. PMID: [37447152](https://pubmed.ncbi.nlm.nih.gov/37447152/)
<figure>
  <img src="https://pdfs.citedhealth.com/figures/37447152/218.png" alt="Subgroup analyses stratify cognitive outcomes by baseline DHA status, revealing whether individuals with lower initial omega-3 levels benefit more from supplementation." />
  <figcaption>Figure 13. Subgroup analyses stratify cognitive outcomes by baseline DHA status, revealing whether individuals with lower initial omega-3 levels benefit more from supplementation.<br>  Source: Toshiaki Sueyasu et al. "Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and." <em>Nutrients</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37447152/">37447152</a></figcaption>
</figure>

Verwandte Evidenz

A
Omega-3 Fatty Acids (DHA/EPA) für Age-Related Cognitive Decline

Bewertung A · 58 Studien

 C
Lutein & Zeaxanthin für Age-Related Cognitive Decline

Bewertung C · 8 Studien